SynthesisWorld journal of surgical oncology2025

Comparative efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors versus tyrosine kinase inhibitors and immune checkpoint inhibitors alone in advanced hepatocellular carcinoma: a systematic review and meta-analysis.

Hengyu Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.